In South Africa, and worldwide, rheumatic fever represents a public health problem. Improved diagnosis and management of Sydenham chorea, a major manifestation of acute rheumatic fever is key to prevention of rheumatic heart disease. This article reviews Sydenham chorea from its original description to current opinions. Recommendations are founded on expert opinion as class 1 data is lacking. This South African perspective is relevant to resource-poor settings globally insofar as it provides diagnosis and management recommendations for primary- and secondary-level healthcare professionals who care for patients in such environments. Four basic tenets of care are recommended, namely, elimination of the streptococcal infection, symptomatic treatment, immunological treatment, and nonpharmacologic interventions. A user-friendly outcome measurement tool, viable for use in low-resource settings is presented. Introduction of this tool may lead to increased awareness of the neuropsychiatric manifestations of poststreptococcal movement disorders in Africa, where reports are limited.
SliwaKCarringtonMMayosiBMZigiriadisEMvungiRStewartS. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719–727.
4.
SliwaKMocumbiAO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol. 2010;99:65–74.
AkinyemiROOkubadejoNU. Movement disorders in Africa: a review. Arch Ibadan Med. 2010;10:58–64.
7.
RobertsonMM. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed. 2012;97:166–175.
8.
CardosoF. Sydenham chorea. In: DaleRVincentA, eds. Inflammatory and Autoimmune Disorders of the Nervous System in Children. 1st ed. London: Mac Keith Press; 2010:120–133.
9.
GarveyMAAsbahrFR. Sydenham chorea. In: GuerriniRAicardiJAndermannFHallettM, eds. Epilepsy and Movement Disorders. Boston: Cambridge University Press; 2002:359–378.
10.
AyoubEM. Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness. Postgrad Med. 1992;92:133–136, 139–142.
WalkerKGCooperMMcCabeK. Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Cardiol Young. 2011; 21:328–333.
13.
WalkerKLawrensonJWilmshurstJ. Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol. 2005;47:771–775.
14.
WalkerKGWilmshurstJM. An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010;3:301–309.
15.
MooreDP. Neuropsychiatric aspects of Sydenham’s chorea: a comprehensive review. J Clin Psychiatry. 1996;57:407–414.
16.
RidelKRLippsTDGilbertDL. The prevalence of neuropsychiatric disorders in Sydenham’s chorea. Pediatr Neurol. 2010;42:243–248.
17.
GordanN. Sydenham’s chorea and its complications affecting the nervous system. Brain Dev. 2009;31:11–14.
18.
AsbahrFRGarveyMASniderLAZanettaDMElkisHSwedoSE. Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry. 2005;57:1073–1076.
19.
GarveyMASwedoSE. Sydenham’s chorea clinical and therapeutic update. Adv Exp Med Biol. 1997;418:115–120.
20.
WalkerKLawrensonJWilmshurstJM. Sydenham’s chorea—clinical and therapeutic update 320 years down the line. S Afr Med J. 2006;96
(9 pt 2):906–912.
21.
Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. J Am Med Assoc. 1992;268:2069–2073.
22.
CarapetisJRCurrieBJ. Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child. 1999;80:353–358.
23.
DaleRCHeymanISurteesRA. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child. 2004;89:604–610.
24.
DaleRC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol. 2005;47:785–791.
25.
EdgarTS. Oral pharmacotherapy of childhood movement disorders. J Child Neurol. 2003;18:840–849.
26.
van ToornRWeyersHHSchoemanJF. Distinguishing PANDAS from Sydenham’s chorea: case report and review of the literature. Eur J Paediatr Neurol. 2004;8:211–216.
27.
SwedoSLeonardHLGarveyMA. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271.
28.
SwedoSLeckmanJRoseN. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therap. 2012;2:113–121.
29.
BrimbergLiorBenharItaiMascaro-BlancoAdita. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology. 2012;37:2076–2087.
30.
PavonePParanoERizzoRTrifilettiRR. Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol. 2006;21:727–736.
31.
SwedoSELeonardHLRapoportJL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004;113:907–911.
32.
SniderLASwedoSE. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol. 2003;16:359–365.
33.
SniderLASwedoSE. PANDAS: current status and directions for research. Mol Psychiatry. 2004;9:900–907.
34.
DaleRCMerhebVPillaiS. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135:3453–3468.
35.
HusbyGVan de RinjIZabriskieJBAbdinAHWilliamsRC. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;114:1094–1110.
36.
ChurchAJDaleRCCardosoF. CSF and serum immune parameters in Sydenham’s chorea: evidence of an autoimmune syndrome?J Neuroimmunol. 2003;136:149–153.
37.
ChurchAJCardosoFDaleRCLeesAJThompsonEJGiovannoniG. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002;59:227–231.
38.
DaleRCHeymanIGiovannoniGChurchAW. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry. 2005;187:314–319.
39.
SwedoSE.Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. J Am Med Assoc. 1994;272:1788–1791.
40.
DaleRCHeymanI. Post-streptococcal autoimmune psychiatric and movement disorders in children. Br J Psychiatry. 2002;181:188–190.
41.
MarijonECelermajerDSTaffletM. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009;120:663–668.
42.
ZuhlkeLJMirabelMMarijonE. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99:1554–1561.
43.
EkiciFCetinICevikBSenkonOAlpanNDegerliyurtA. What is the outcome of rheumatic carditis in children with Sydenham’s chorea?Turk J Pediatr. 2012;54:159–167.
44.
PastoreSDe CuntoABenettoniABertonETaddioALeporeL. The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford). 2011;50:396–400.
45.
BronzMDaleJ. Epitopes of streptococcal M proteins that evolve antibodies that cross-react with human brain. J Immunol. 1993;151:2820–2828.
46.
GarveyMAGieddJSwedoSE. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol. 1998;13:413–423.
47.
GarveyMAPerlmutterSJAllenAJ. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45:1564–1571.
48.
SniderLALougeeLSlatteryMGrantPSwedoS. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuro-psychiatric disorders. Biol Psychiatry. 2005;57:788–792.
49.
PerrinEMMurphyMCaseyJ. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?Arch Pediatr Adolesc Med. 2004;158:848–856.
50.
WillmshurstJMCrossJHNewtonC. Children with epilepsy in Africa: recommendations from the International Child Neurology Association/African Child Neurology Association Workshop. J Child Neurol. 2013;28:633–644.
51.
CarapetisJRZuhlkeLJ. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011;4:4–12.
52.
PavlovicDMPavlovicAM. Antiphospholipid syndrome in neurology. Srp Arh Celok Lek. 2010;138:651–657.
53.
SwedoSELeonardHLMittlemanBB. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110–112.
54.
Al-EissaA. Sydenham’s chorea: a new look at an old disease. Br J Clin Pract. 1993;47:14–16.
55.
GieddJRapoportJLGarveyMAPerlmutterSJSwedoSE. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 2000;157:281–283.
56.
WalkerKBrinkALawrensonJMathiassenWWilmshurstJM. Treatment of Sydenham chorea with intravenous immunoglobulin. J Child Neurol. 2012;27:147–155.
57.
CitakECGucuyenerKKarabacakNISerdarogluAOkuyazCAydinK. Functional brain imaging in Sydenham’s chorea and streptococcal tic disorders. J Child Neurol. 2004;19:387–390.
58.
BarsottiniOGFerrazHBSevilianoMMBarbieriA. Brain SPECT imaging in Sydenham’s chorea. Braz J Med Biol Res. 2002;35:431–436.
59.
BeatoRSiqueiraCFMarroniBJ. Brain SPECT in Sydenham’s chorea in remission. Mov Disord. 2014;29:256–258.
60.
AronAMFreemanJMCarterS. The natural history of Sydenham’s chorea. Am J Med. 1965;38:83–94.
61.
TeixeiraALJrMaiaDPCardosoF. The initial testing and the discrimination property of the UFMG Sydenham’s Chorea Rating Scale (USCRS)]. Arq Neuropsiquiatr2005;63
(3B):825–827.
MayosiBRobertsonKVolminkJ. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J. 2006;96
(3 pt 2):246.
64.
RobertsonKAVolminkJAMayosiBM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa—the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J. 2006;96:241–245.
65.
CarapetisJRBrownAWilsonNJEdwardsKN, Rheumatic Fever Guidelines Writing Group. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust. 2007;186:581–586.
66.
CilliersAM. Rheumatic fever and its management. BMJ. 2006;333:1153–1156.
67.
ManyembaJMayosiBM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever—a systematic review. S Afr Med J. 2003;93:212–218.
68.
AmirJGinatSCohenYHMarcusTEKellerNVarsanoI. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J. 1998;17:890–893.
69.
RosenbergG. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?Cell Mol Life Sci. 2007;64:2090–2103.
70.
KulkarniML. Sodium valproate in Sydenham’s chorea. Indian Pediatr. 1992 Mar;29:385–386.
71.
PazJASilvaCAMarques-DiasMJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34:264–269.
72.
TeixeiraALJrMaiaDPCardosoF. Treatment of acute Sydenham’s chorea with methyl-prednisolone pulse-therapy. Parkinsonism Relat Disord. 2005;11:327–330.
73.
TeixeiraALJrCardosoF. Corticosteroids in the treatment of acute Sydenham’s chorea. Pediatr Neurol. 2006;34:168–169; author reply 169.
74.
HolmanHLorigK. Patients as partners in managing chronic disease. BMJ. 2000;320:526–527.
75.
GharagozlooRADaneshpajoohMGhavamianP. Rheumatic fever and rheumatic heart disease among 56,8000 inhabitants in southeast Teheran from 1972-1974. Acta Trop. 1976;33:215–222.
76.
DemirorenKYavuzHCanLOranBKaraaslanSDemirorenS. Sydenham’s chorea: a clinical follow-up of 65 patients. J Child Neurol. 2007;22:550–554.
77.
McDonaldMBrownANoonanSCarapetisJR. Preventing recurrent rheumatic fever: the role of register based programmes. Heart. 2005;91:1131–1133.
